5 Simple Statements About what type of drug is nembutal Explained
5 Simple Statements About what type of drug is nembutal Explained
Blog Article
pentobarbital will minimize the level or influence of verapamil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will lower the level or influence of tofacitinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe. Lack of, or reduced reaction to tofacitinib may well arise when coadministered with potent CYP3A4 inducers
pentobarbital will decrease the extent or influence of ethotoin by impacting hepatic enzyme CYP2C9/10 metabolism. Use Warning/Observe.
pentobarbital will minimize the level or influence of buprenorphine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
Keep track of Intently (1)pentobarbital will lessen the level or result of linagliptin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of. Use of different remedies is strongly advisable when linagliptin is to be administered by using a CYP3A4 inducer
pentobarbital will reduce the extent or result of irinotecan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
pentobarbital will minimize the extent or influence of abemaciclib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or more info Use Alternate Drug. Coadministration of abemaciclib with robust CYP3A4 inducers decreases plasma concentration of abemaciclib and its metabolites.
pentobarbital will decrease the level or impact of venetoclax by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
Contraindicated (one)pentobarbital will lower the extent or result of lumefantrine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with robust CYP3A4 inducers can result in lowered serum concentrations and lack of antimalarial efficacy
펜토바르비탈은 라이 증후군의 두개내의 압력을 줄이기 위해 사용되며, 또한 대뇌 빈혈환자의 뇌 손상을 줄이고, 뇌사를 낮추기 위해 사용된다.
pentobarbital will lessen the extent or outcome of lumefantrine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with strong CYP3A4 inducers can result in reduced serum concentrations and loss of antimalarial efficacy
pentobarbital will lessen the level or influence of netupitant/palonosetron by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. Netupitant is especially metabolized by CYP3A4; keep away from use in patients who're chronically applying a powerful CYP3A4 inducer
pentobarbital will lower the level or impact of amlodipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will decrease the extent or influence of bortezomib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.